	Vertriebs- Und Verwaltungskosten		Datum
Acadia Pharmaceuticals	USD 124.9M	1.24M	2025-09
Agios Pharmaceuticals	USD 42.97M	1.7M	2025-12
Alnylam Pharmaceuticals	USD 285.06M	22.47M	2025-12
Amgen	USD 1.94B	237M	2025-12
Bayer	EUR 3.4B	140M	2025-09
Biogen	USD 545.2M	38.6M	2025-09
BioMarin Pharmaceutical	USD 223.42M	8.86M	2025-09
Gilead Sciences	USD 1.78B	425M	2025-12
Incyte	USD 390.41M	61.33M	2025-12
Insmed	USD 212.48M	26.11M	2025-12
Ionis Pharmaceuticals	USD 86.56M	4.04M	2025-09
Moderna	USD 308M	40M	2025-12
Neurocrine Biosciences	USD 301.8M	10.2M	2025-12
PTC Therapeutics	USD 87.2M	3.15M	2025-12
Puma Biotechnology	USD 16.82M	8.15M	2024-09
Regeneron Pharmaceuticals	USD 775M	117.2M	2025-12
Roche Holding	CHF 7.28B	3.99B	2025-12
Sangamo BioSciences	USD 9.64M	1.83M	2024-06
Sanofi	EUR 2.75B	455M	2025-12
Sarepta Therapeutics	USD 77.11M	7.22M	2025-09
Ultragenyx Pharmaceutical	USD 89M	2.38M	2025-12
United Therapeutics	USD 152M	60.5M	2025-09
Vertex Pharmaceuticals	USD 487M	41.9M	2025-12

BioMarin Pharmaceutical Vertriebs- Und Verwaltungskosten - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.